Literature DB >> 12153158

The role of donor age in naive T-cell recovery following allogeneic hematopoietic stem cell transplantation: the younger the better.

Eiichi Azuma1, Masahiro Hirayama, Hatsumi Yamamoto, Yoshihiro Komada.   

Abstract

The high incidence of opportunistic infections after unrelated bone marrow transplantation has been reported. Delayed lymphocyte recovery may be associated with opportunistic infections. Immune reconstitution is influenced by recipient age and graft-vs-host disease. However, the role of donor age is largely unknown. When the effect of donor age on lymphocyte reconstitution post-transplant was examined in the murine allogeneic hematopoietic stem cell transplantation, the recovery of CD4+ naive T-cells in early post-transplant period was correlated inversely with donor age. Clinically, recipient mice transplanted from younger donors showed significantly higher survival rate and mitogenic responses than adult donors. Since CD4+ naive T-cells are mainly involved in primary immune responses to newly encountered antigens and play an important role in host defense, faster recovery of CD4+ naive T-cells in younger donors may contribute to the reduced mortality in early post-transplant period. Therefore, it is better to choose a younger donor if sufficient cell dose is available. In this review, age-related changes in hematopoiesis and lymphopoiesis as well as thymus-dependent and thymus-independent pathways following allogeneic hematopoietic stem cell transplantation are discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12153158     DOI: 10.1080/10428190290016827

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  10 in total

1.  Low blood lymphocyte count at 30 days post transplant predicts worse acute GVHD and survival but not relapse in a large retrospective cohort.

Authors:  Z Gul; E Van Meter; M Abidi; I Ditah; M Abdul-Hussein; A Deol; L Ayash; L G Lum; E K Waller; V Ratanatharathorn; J Uberti; Z Al-Kadhimi
Journal:  Bone Marrow Transplant       Date:  2015-01-19       Impact factor: 5.483

2.  Stem Cell Aging and Regenerative Medicine.

Authors:  Debojyoti De; Parimal Karmakar; Debalina Bhattacharya
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Allogeneic unrelated bone marrow transplantation from older donors results in worse prognosis in recipients with aplastic anemia.

Authors:  Yasuyuki Arai; Tadakazu Kondo; Hirohito Yamazaki; Katsuto Takenaka; Junichi Sugita; Takeshi Kobayashi; Yukiyasu Ozawa; Naoyuki Uchida; Koji Iwato; Naoki Kobayashi; Yoshiyuki Takahashi; Ken Ishiyama; Takahiro Fukuda; Tatsuo Ichinohe; Yoshiko Atsuta; Takehiko Mori; Takanori Teshima
Journal:  Haematologica       Date:  2016-02-08       Impact factor: 9.941

Review 4.  Tissue-specific accelerated aging in nucleotide excision repair deficiency.

Authors:  Laura J Niedernhofer
Journal:  Mech Ageing Dev       Date:  2008-05-01       Impact factor: 5.432

Review 5.  DNA repair is crucial for maintaining hematopoietic stem cell function.

Authors:  Laura J Niedernhofer
Journal:  DNA Repair (Amst)       Date:  2008-01-08

6.  Anti-CMV-IgG positivity of donors is beneficial for alloHSCT recipients with respect to the better short-term immunological recovery and high level of CD4+CD25high lymphocytes.

Authors:  Emilia Jaskula; Dorota Dlubek; Agnieszka Tarnowska; Janusz Lange; Monika Mordak-Domagala; Krzysztof Suchnicki; Mariola Sedzimirska; Agata Borowik; Sylwia Mizia; Andrzej Lange
Journal:  Viruses       Date:  2015-03-23       Impact factor: 5.048

Review 7.  Immune Reconstitution in the Aging Host: Opportunities for Mechanism-Based Therapy in Allogeneic Hematopoietic Cell Transplantation.

Authors:  Richard J Lin; Harold K Elias; Marcel R M van den Brink
Journal:  Front Immunol       Date:  2021-04-19       Impact factor: 7.561

Review 8.  Immune Reconstitution After Allogeneic Haematopoietic Cell Transplantation: From Observational Studies to Targeted Interventions.

Authors:  Asaf Yanir; Ansgar Schulz; Anita Lawitschka; Stefan Nierkens; Matthias Eyrich
Journal:  Front Pediatr       Date:  2022-01-11       Impact factor: 3.418

9.  Donor Age and Non-Relapse Mortality: Study of Their Association after HLA-Matched Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome.

Authors:  Yasmine Kadri; Michelle Phan; Nadia Bambace; Léa Bernard; Sandra Cohen; Jean-Sébastien Delisle; Thomas Kiss; Sylvie Lachance; Denis-Claude Roy; Guy Sauvageau; Olivier Veilleux; Jean Roy; Imran Ahmad
Journal:  Curr Oncol       Date:  2022-08-22       Impact factor: 3.109

Review 10.  Immune Monitoring After Allogeneic Hematopoietic Cell Transplantation: Toward Practical Guidelines and Standardization.

Authors:  Jaap Jan Boelens; Kinga K Hosszu; Stefan Nierkens
Journal:  Front Pediatr       Date:  2020-08-21       Impact factor: 3.418

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.